Discrete-event simulation models in the economic evaluation of health technologies and health products;Los modelos de simulación de eventos discretos en la evaluación económica de tecnologías y productos sanitarios

Gaceta Sanitaria

Volumn 22, Issue 2, 2008, Pages 151-161

  Barrios, José Manuel Rodríguez ^a,e   Serrano, David ^a   Monleón, Toni ^b   Caro, Jaime ^c,d  

^a Medtronic Iberica SA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c CARO RESEARCH INSTITUTE   (United States)

^d MCGILL UNIVERSITY   (Canada)

^e SA   (Spain)

Author keywords

Computer simulation; Discrete event simulation; Economic evaluation models; Health technologies

Indexed keywords

EID: 42249107349     PISSN: 02139111     EISSN: 15781283     Source Type: Journal    
DOI: 10.1157/13119326     Document Type: Review

References (23)

1. Rodríguez Barrios JM. El papel de los modelos en la evaluación económica en el campo sanitario. Farm Hosp. 2004;28:31-242.
2. Weinstein MC, Toy EL, Sandberg EA, Neumann PJ, Evans JS, Kuntz KM, et al. Modeling for health care and other policy decisions: uses, roles, and validity. Values Health. 2001;4:348-61.
3. Greenberg PE, Arcelus A, Birnbaum HG, Cremieux PY, Le-Lorier J, Ouellette P, et al. Pharmacoeconomics and health policy. Current applications and prospects for the future. PharmacoEconomics. 1999;16:425-32.
4. Chang K, Nash D. The role of pharmacoeconomic evaluations in disease management. PharmacoEconomics. 1998;14:11-7.
5. Weinstein MC, O'Brien B, Hornberger J, Jackson J, Johannesson M, McCabe C, et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices-Modeling Studies. Value Health. 2003;6:9-17.
6. Greenberg PE, Arcelus A, Birnbaum HG, Cremieux PY, Le-Lorier J, Ouellette P, et al. Pharmacoeconomics and health policy. Current applications and prospects for the future. PharmacoEconomics. 1999;16:425-32.
7. Chang K, Nash D. The role of pharmacoeconomic evaluations in disease management. PharmacoEconomics. 1998;14:11-7.
8. Law A. How to conduct a successful simulation study. Proceedings of the Winter Simulation Conference, 2003.
9. Barceló J. Simulación de sistemas discretos. Madrid: Isdefe; 1996.
10. Guasch A, Piera MA, Casanovas J, Figueres J. Modelado y simulación. Barcelona: UPC; 2002.
11. Chung C. Simulation modeling handbook: a practical approach. Boca Ratón: CRC Press; 2004.
12. Carson J. Introduction to modeling and simulation. Proceedings of the Winter Simulation Conference, 2003.
13. Banks J. Introduction to simulation. Proceedings of the Winter Simulation Conference, 1999.
14. Monleón T, Ocaña J. La simulación como herramienta de optimización de la investigación clínica. Med Clin (Barc). 2006;127:702-4.
15. Monleón T. Optimización de los ensayos clínicos de fármacos mediante simulación de eventos discretos, su modelización, validación, verificación y la mejora de la calidad de sus datos [tesis doctoral]. Barcelona: Universidad de Barcelona; 2005. Disponible en: http://www.tesisenxarxa.net/TDX-0112106-093218
16. Sargent RG. Verification and validation of simulation models. Proceedings of the Winter Simulation Conference, 2003.
17. Averill ML, Kelton WD. Simulation modeling & analysis. 2nd ed. New York: McGraw-Hill International Editions. Industrial Engineering Series; 1991.
18. Deák I. Random number generation and simulation. Budapest: Akadémiai Kiadó; 1990.
19. Kalos MH, Whitlock PA. Monte Carlo Methods, Volume I: Basics. Wiley, N.Y. 1986.
20. Rubinstein RY. Simulation and the Monte Carlo method. New York: John Wiley & Sons; 1981.
21. Caro J, Ward A, Moller J. Modelling the health benefits and economic implications of implanting dual-chamber vs. single-chamber ventricular pacemakers in the UK. Europace. 2006;8:449-55.
22. Caro JJ. Discrete event simulation in pharmacoeconomic analysis. Pharmacoeconomics. 2005;23:323-32.
23. Rodríguez Barrios JM, Hernández Velasco CI. Análisis farmacoeconómico mediante simulación de eventos discretos: una metodología emergente. Gestión Clínica y Sanitaria. 2006;3:21.